{
  "catalogId": "79c26e12-06f0-477a-8b4d-927bf39ba584",
  "name": "RIPALID 0.5 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "159 05 34990 00",
  "treatmentDescriptions": "Ripalid is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Ripalid is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "REPAGLINIDE 0.5  MG",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "A10BX02",
      "name": "REPAGLINIDE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "RIPALID 0.5 MG 90 \tTABLETS",
      "manufacturer": {
        "name": "פאדאגיס",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 90.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER ALUMINIUM /ALUMINIUM",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "8073",
        "yarpa": "63286",
        "pharmasoft": "18571"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 18.4348,
        "retailMargin": 37.0,
        "maxRetailPrice": 25.255676,
        "maxPriceWithVAT": 29.80169768
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.623668"
  }
}